Medical Cannabis(Syqe Medical)

N/A

Report date: 2026/03/04 20:01:44

Base Information

Drug NameMedical Cannabis(Syqe Medical)
Drug Alias NameBedrocan
ClassificationSmall molecules
Mechanisms of ActionCannabinoid receptor modulators
TargetsCannabinoid receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingDiabetic NeuropathiesCarcinoma, Hepatocellular
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaUnited StatesPoland +[7] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesSyqe Medical Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Medical Center GroningenUniversity Of RochesterSyqe Medical Ltd
Inactive CompaniesN/A
Active IndicationsChemotherapy-induced nausea and vomitingDiabetic NeuropathiesCarcinoma, Hepatocellular
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A